Innovative Drug Development Approach to Address the Transition to Low Global Warming Potential Propellant Using Hydrofluoroalkane-152a, for Triple Combination Pressurized Metered-Dose Inhaler Products Targeting Small Airways.

Saved in:
Bibliographic Details
Title: Innovative Drug Development Approach to Address the Transition to Low Global Warming Potential Propellant Using Hydrofluoroalkane-152a, for Triple Combination Pressurized Metered-Dose Inhaler Products Targeting Small Airways.
Authors: Matturro A; Global Technical Development, R&D, Chiesi Farmaceutici S.P.A, L.Go Belloli 11/A, 43122, Parma, Italy. ab.matturro@chiesi.com., Zambelli E; Global Technical Development, R&D, Chiesi Farmaceutici S.P.A, L.Go Belloli 11/A, 43122, Parma, Italy., Cuoghi E; Global Technical Development, R&D, Chiesi Farmaceutici S.P.A, L.Go Belloli 11/A, 43122, Parma, Italy., Copelli D; Global Technical Development, R&D, Chiesi Farmaceutici S.P.A, L.Go Belloli 11/A, 43122, Parma, Italy., Usberti F; Global Technical Development, R&D, Chiesi Farmaceutici S.P.A, L.Go Belloli 11/A, 43122, Parma, Italy., Fioni A; Department of Pharmacokinetics, Biochemistry and Metabolism, R&D, Chiesi Farmaceutici S.P.A, Parma, Italy., Labadini L; AIR Pipeline Development, Chiesi Farmaceutici S.P.A, Parma, Italy.
Source: AAPS PharmSciTech [AAPS PharmSciTech] 2025 Feb 26; Vol. 26 (3), pp. 72. Date of Electronic Publication: 2025 Feb 26.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932 (Electronic) Linking ISSN: 15309932 NLM ISO Abbreviation: AAPS PharmSciTech Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1530-9932
DOI:10.1208/s12249-025-03057-z